- Home
- BIGC vs SANA Comparison
BIGC vs SANA Comparison
Compare BIGC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIGC
- SANA
- Stock Information
- Founded
- BIGC 2009
- SANA 2018
- Country
- BIGC United States
- SANA United States
- Employees
- BIGC N/A
- SANA N/A
- Industry
- BIGC Computer Software: Prepackaged Software
- SANA Medicinal Chemicals and Botanical Products
- Sector
- BIGC Technology
- SANA Health Care
- Exchange
- BIGC Nasdaq
- SANA Nasdaq
- Market Cap
- BIGC 453.4M
- SANA 519.8M
- IPO Year
- BIGC 2020
- SANA 2021
- Fundamental
- Price
- BIGC $5.36
- SANA $1.77
- Analyst Decision
- BIGC Hold
- SANA Strong Buy
- Analyst Count
- BIGC 6
- SANA 5
- Target Price
- BIGC $7.50
- SANA $9.50
- AVG Volume (30 Days)
- BIGC 831.3K
- SANA 3.9M
- Earning Date
- BIGC 05-08-2025
- SANA 05-07-2025
- Dividend Yield
- BIGC N/A
- SANA N/A
- EPS Growth
- BIGC N/A
- SANA N/A
- EPS
- BIGC N/A
- SANA N/A
- Revenue
- BIGC $332,927,000.00
- SANA N/A
- Revenue This Year
- BIGC $5.97
- SANA N/A
- Revenue Next Year
- BIGC $5.98
- SANA N/A
- P/E Ratio
- BIGC N/A
- SANA N/A
- Revenue Growth
- BIGC 7.61
- SANA N/A
- 52 Week Low
- BIGC $4.85
- SANA $1.26
- 52 Week High
- BIGC $8.60
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- BIGC 46.32
- SANA 47.51
- Support Level
- BIGC $5.02
- SANA $1.53
- Resistance Level
- BIGC $5.22
- SANA $1.91
- Average True Range (ATR)
- BIGC 0.30
- SANA 0.20
- MACD
- BIGC 0.03
- SANA 0.06
- Stochastic Oscillator
- BIGC 56.67
- SANA 75.00
About BIGC BigCommerce Holdings Inc. Series 1
BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of revenue is generated from Americas-U.S.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.